1-Methyl-3-nitro-1-nitrosoguanidine 1-甲基-3-硝基-1-亚硝基胍

CAS 70-25-7 MFCD00007034

化学结构图

70-25-7
SMILES: CN(N=O)C(=N)N[N+](=O)[O-]

化学属性

Mol. FormulaC2H5N5O3
Mol. Weight147
Melting Point118°C
Solubility起反应 VIOLENTLY
Density1.764
Stability对热和光敏感

别名和识别编码

Chemical Name1-Methyl-3-nitro-1-nitrosoguanidine
CAS Number70-25-7
Synonym N-METHYL-N'-NITRO-N-NITROSOGUANIDINE N-甲基-N'-硝基-N-亚硝基胍;MNNG 1-METHYL-3-NITRO-1-NITROSOGUANIDINE N-Methyl-N?-nitro-N-nitroso-guanidine N-Nitroso-N-methylnitroguanidine 1-Methyl-1-nitroso-3-nitroguanidine DIAZOMETHANE PRECURSOR RCRA waste number U163 N-甲基-N'-硝基-N-亚硝基胍 N'-Nitro-N-nitroso-N-methylguanidine MNG n-methyl-n’-nitro-n-nitroso-guanidin N-Methyl-N-nitroso-N'-nitroguanidine n-metylo-n’-nitro-n-nitrozoguanidyny 1-methyl-3-nitro-1-nitroso-guanidin N-Metylo-N'-nitro-N-nitrozoguanidyny N-Methyl-N'-nitro-N-nitrosoguanidine; Diazomethane precursor; MNNG 1-甲基3-硝基1-亚硝基胍(0309禁空运) 1-Methyl-1-nitroso-2-nitroguanidine N-Nitrosoguanidine 1-甲基-3-硝基-1-亚硝基胍(MNNG) 1-甲基3-硝基1-亚硝基胍(无法供) n’-nitro-n-nitroso-n-methylguanidine 1-nitroso-3-nitro-1-methylguanidine Guanidine, 1-methyl-3-nitro-1-nitroso- MNNG nci-c01423 N-Methyl-N',2-dioxohydrazinecarboximidohydrazide 2-oxide N-Methyl-N'-nitro-N-nitrosoguanidine N-METHYL-N-NITROSO-N'-NITROGUANIDINE Methylnitronitrosoguanidine 1-Methyl-1-Nitroso-3-nitroguanidine Guanidine, N-methyl-N'-nitro-N-nitroso- 1-Methyl-3-nitro-1-nitrosoguanidine N-Nitroso-N?-nitro-N-methylguanidine NA 1325 n-methylo-n’-nitro-n-nitrozoguanidyny(polish) NSC 9369 1-甲基-3-硝基-1-亚硝基胍 mnng(n-methyl-n’-nitro-n-nitrosoguanidine N-Methyl-N-nitrosonitroguanidin N-甲基-N′-硝基-N-亚硝基胍 MNNG 重氮甲烷前体
MDL NumberMFCD00007034
PubChem Substance ID87572565
Beilstein Registry Number1779490
EC Number200-730-1
Reaxys-RN1779490
Merck Number6103
Chemical Name Translation1-甲基-3-硝基-1-亚硝基胍
Wiswesser Line NotationWNMYUM&N1&NO
LabNetwork Molecule IDLN01301420
InChIInChI=1S/C2H5N5O3/c1-6(5-8)2(3)4-7(9)10/h1H3,(H2,3,4)
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

分类

  • Mutagenesis Research Chemicals

产品应用

  • A DNA-damaging agent, used as a positive control in SHE cell transformation assays.

相关文献及参考

  • Merck: 14,6103 Beilstein: 4,IV,3386
  • Zhu, H., et al.: Environ. Toxicol., Pharmacol., 29, 79 (2010),
  • Merck: 14,6103
  • Tang, J., et al.: Mol. Canc. Res., 8, 67 (2010),
  • Suleyman, H., et al.: Int. J. Canc., 126, 1740 (2010),

安全信息

RTECSMF4200000
GHS Symbol
Precautionary statements
  • P362 Take off contaminated clothing and wash before reuse. 脱掉污染的衣服,清洗后方可重新使用
  • P308+P313
  • P305+P351+P338
  • P273 Avoid release to the environment. 避免释放到环境中。
  • P201 Obtain special instructions before use. 使用前获取专门指示。
  • P280 Wear protective gloves/protective clothing/eye protection/face protection. 戴防护手套/防护服/眼睛的保护物/面部保护物。
  • P332+P313
  • P501 Dispose of contents/container to..… 处理内容物/容器.....
  • P302+P350
  • P337+P313
  • P241 Use explosion-proof electrical/ventilating/lighting/…/equipment. 使用防爆电气/通风/照明/ .../设备。
  • P302+P352+P332+P313+P362+P364
  • P264 Wash hands thoroughly after handling. 处理后要彻底洗净双手。
  • P240 Ground/bond container and receiving equipment. 与地面接触/连接集装箱和接受设备。
  • P270 Do not eat, drink or smoke when using this product. 使用本产品时不要吃东西,喝水或吸烟。
  • P202 Do not handle until all safety precautions have been read and understood. 已阅读并理解所有的安全预防措施之前,切勿操作。
  • P304+P340+P312
  • P261 Avoid breathing dust/fume/gas/mist/vapours/spray. 避免吸入粉尘/烟/气体/烟雾/蒸汽/喷雾。
  • P210 Keep away from heat/sparks/open flames/hot surfaces. — No smoking. 远离热源/火花/明火/热的表面。——禁止吸烟。
  • P305+P351+P338+P337+P313
Hazard statements
  • H332 Harmful if inhaled 吸入有害
  • H315 Causes skin irritation 会刺激皮肤
  • H411 Toxictoaquaticlifewithlonglastingeffects 对水生生物有毒性并具有长期影响。
  • H319 Causes serious eye irritation 严重刺激眼睛
  • H350 May cause cancer 可能致癌
  • H228 Flammable solid 易燃固体
WGK Germany3
Personal Protective Equipment Eyeshields, Faceshields, full-face particle respirator type N100 (US), Gloves, respirator cartridge type N100 (US), type P1 (EN143) respirator filter, type P3 (EN 143) respirator cartridges
Signal word Danger
Hazard Codes T;N,N,T T;N
Safety Statements
  • S45 In case of accident or if you feel unwell seek medical advice immediately (show the label where possible) 发生事故时或感觉不适时,立即求医(可能时出示标签);
  • S53 Avoid exposure - obtain special instructions before use 避免接触,使用前获得特别指示说明;
  • S61 Avoid release to the environment. Refer to special instructions/safety data sheet 避免释放到环境中,参考特别指示/安全收据说明书;
Risk Statements
  • R45 May cause cancer 可能致癌
  • R36/38 Irritating to eyes and skin 对眼睛和皮肤有刺激性
  • R51/53
  • R20 Harmful by inhalation 吸入有害
UN Number 1325 2926
Storage condition 0-10 储存温度2-8℃ 0-10°C 0-6°C
Packing GroupII
Hazard Class4.1/6.1
TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - hamster
DOSE/DURATION           : 592 mg/kg/27W-C
TOXIC EFFECTS :
   Tumorigenic - equivocal tumorigenic agent by RTECS criteria
   Gastrointestinal - tumors
REFERENCE :
   CNREA8 Cancer Research. (Public Ledger Building, Suit 816, 6th & Chestnut
   Sts., Philadelphia, PA 19106)  V.1-    1941-  Volume(issue)/page/year:
   30,1444,1970

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Subcutaneous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 400 ug/kg
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criter

{haz

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Parenteral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 400 ug/kg
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Tumorigenic - tumors at site of application
REFERENCE :
   ARTODN Archives of Toxicology.  (Springer-Verlag, Heidelberger Pl. 3, D-1000
   Berlin 33, Fed. Rep. Ger.)  V.32-    1974-  Volume(issue)/page/year:

{

TYPE OF TEST            : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 651 mg/kg/34W-C
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteria
   Gastrointestinal - tumors
REFERENCE :
   VOONAW Voprosy Onkologii.  Problems of Oncology.  For English translation,
   see PONCAU. (V/O Mezhdunarodnaya Kniga, 113095 Moscow, USSR)  V.1-10,
   1928-37; V.1-    1955-  Volume(issue)/page/year: 28(9),34,1982

TYPE OF TEST            : TD - Toxic dose (other than lowest)
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 13500 mg/kg/78W-C
TOXIC EFFECTS :
   Tumorigenic - Carcinogenic by RTECS criteri

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - rat
DOSE/DURATION           : 80 mg/kg
TOXIC EFFECTS :
   Lungs, Thorax, or Respiration - acute pulmonary edema
   Behavioral - convulsions or effect on seizure threshold
REFERENCE :
   EJCAAH European Journal of Cancer.  (Oxford, UK)  V.1-17(6), 1965-1981. For
   publisher information, see EJCODS.  Volume(issue)/page/year: 16,395,1980

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Oral
SPECIES OBSERVED        : Rodent - hamster
DOSE/DURATION           : 1070 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   CALEDQ Cancer Letters (Shannon, Ireland).  (Elsevier Scientific Pub. Ireland
   Ltd., POB 85, Limerick, Ireland)  V.1-    1975- Volume(issue)/page/year:
   4,241,1978

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intravenous
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 37300 ug/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   NCISP* National Cancer Institute Screening Program Data Summary,
   Developmental Therapeutics Program. (Bethesda, MD 20205)
   Volume(issue)/page/year: JAN1986

TYPE OF TEST            : LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE/DURATION           : 66 mg/kg
TOXIC EFFECTS :
   Details of toxic effects not reported other than lethal dose value
REFERENCE :
   JJIND8 JNCI, Journal of the National Cancer Institute.  (Washington, DC)
   V.61-79, 1978-87. For publisher information, see JNCIEQ.
   Volume(issue)/page/year: 62,911,1979

{haz

TYPE OF TEST            : DNA inhibition
TEST SYSTEM             : Human Lung
DOSE/DURATION           : 1 mg/L/3H (Continuous)
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 12,183,1971

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Bacteria - Salmonella typhimurium
DOSE/DURATION           : 310 ng/plate
REFERENCE :
   MUREAV Mutation Research.  (Elsevier Science Pub. B.V., POB 211, 1000 AE
   Amsterdam, Netherlands) V.1-    1964-  Volume(issue)/page/year: 130,79,1984

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Microorganism - not otherwise specified
DOSE/DURATION           : 50 mg/L/30M (Continuous)
REFERENCE :
   JGMIAN Journal of General Microbiology.  (Soc. for General Microbiology,
   Journal Sales, 62 London Rd., Reading, RG1 5AS, UK)  V.1-    1947-
   Volume(issue)/page/year: 121,349,1980

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Microorganism - not otherwise specified
DOSE/DURATION           : 1 gm/L
REFERENCE :
   JANTAJ Journal of Antibiotics.  (Japan Antibiotics Research Assoc., 2-20-8
   Kamiosaki, Shinagawa-ku, Tokyo, 141, Japan)  V.2-5, 1948-52;  V.21- 1968-
   Volume(issue)/page/year: 31,662,1978

TYPE OF TEST            : Mutation in microorganisms
TEST SYSTEM             : Microorganism - not otherwise specified
DOSE/DURATION           : 10 mg/L
REFERENCE :
   JGMIAN Journal of General Microbiology.  (Soc. for General Microbiology,
   Journal Sales, 62 London Rd., Reading, RG1 5AS, UK)  V.1-    1947-
   Volume(issue)/page/year: 128,1401,1982

TYPE OF TEST            : Mutation in mammalian somatic cells
TEST SYSTEM             : Rodent - mouse Cells - not otherwise specified
DOSE/DURATION           : 1 mg/L
REFERENCE :
   GANNA2 G

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 50 mg/kg
SEX/DURATION            : female 11 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - cytological changes (including
   somatic cell genetic material)
   Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
   TJADAB Teratology, The International Journal of Abnormal Development. (Alan
   R. Liss, Inc., 41 E. 11th St., New York, NY 10003)  V.1-    1968-
   Volume(issue)/page/year: 25(2),60A,1982

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 40 mg/kg
SEX/DURATION            : female 10 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Fertility - post-implantation mortality (e.g. dead and/or
   resorbed implants per total number of implants)
REFERENCE :
   TJADAB Teratology, The International Journal of Abnormal Development. (Alan
   R. Liss, Inc., 41 E. 11th St., New York, NY 10003)  V.1-    1968-
   Volume(issue)/page/year: 18,263,1978

TYPE OF TEST            : TDLo - Lowest published toxic dose
ROUTE OF EXPOSURE       : Intraperitoneal
SPECIES OBSERVED        : Rodent - mouse
DOSE                    : 25 mg/kg
SEX/DURATION            : female 11 day(s) after conception
TOXIC EFFECTS :
   Reproductive - Effects on Embryo or Fetus - fetotoxicity (except death,
   e.g., stunted fetus)
   Reproductive - Specific Developmental Abnormalities - musculoskeletal system
REFERENCE :
   TCMUD8 Teratogenesis, Carcinogenesis, and Mutagenesis.  (Alan R. Liss, Inc.,
   41 E. 11th St., New York, NY 10003)  V.1-    1980- Volume(issue)/page/year:
   3,335,1983

TYPE OF TEST            : TDLo - Lowest published toxic dos

其他信息

  • 1-甲基-3-硝基-1-亚硝基胍价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2011/08/23 TM052701 1-甲基-3-硝基-1-亚硝基胍(+4℃) 5g 661元 2011/04/16 M0527 1-甲基-3-硝基-1-亚硝基胍(加约50%水湿润,本品干重约为5g) 1-Methyl-3-nitro-1-nitrosoguanidine (wetted with ca. 50% Water, containing 5g on a dry weight basis) 5G 617元
  • 上游原料:乙醇 --> 甲醇 --> 硫酸 --> 硝酸 --> 亚硝酸钠 --> 正丁醇 --> 一甲胺 --> S-甲基异硫脲硫酸盐 --> 氰胺 --> 硝基胍 --> 1-甲基-3-硝基胍
  • MOL 文件:70-25-7.mol
  • TCI Shanghai:N-甲基-N'-硝基-N-亚硝基胍(加约50%水湿润,本品干重约为5g) N-Methyl-N'-nitro-N-nitrosoguanidine (wetted with ca. 50% Water, containing 5g on a dry weight basis),>;95.0%(T)(70-25-7)
  • 不溶于水,保存于水中。
  • 存储注意事项:光敏感
  • Sigma Aldrich:70-25-7(sigmaaldrich)

系列性分类


相关产品推荐